An Open-Label, Randomized, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Fesoterodine On The Pharmacokinetics And Pharmacodynamics Of A Single Supratherapeutic Dose Of Warfarin In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 31 May 2011
At a glance
- Drugs Fesoterodine; Warfarin
- Indications Overactive bladder; Thrombosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Pfizer
- 31 May 2011 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 09 Sep 2009 Additional location (USA) identified as reported by ClinicalTrials.gov.
- 09 Sep 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov